Viridian Therapeutics | DEFA14A: Others
Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Viridian Therapeutics | DEFA14A: Others
Viridian Therapeutics | DEF 14A: Definitive information statements
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Viridian Therapeutics | 8-K: Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Viridian Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Viridian Therapeutics | 8-K: Current report
Viridian Therapeutics | 8-K: Current report
No Data